DrugPatentWatch Database Preview
Teligent Company Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the competitive landscape for TELIGENT, and what generic and branded alternatives to TELIGENT drugs are available?
TELIGENT has fifty-five approved drugs.
Summary for Teligent
| US Patents: | 0 |
| Tradenames: | 38 |
| Ingredients: | 33 |
| NDAs: | 55 |
| Patent Litigation for Teligent: | See patent lawsuits for Teligent |
Drugs and US Patents for Teligent
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teligent | ZINACEF IN PLASTIC CONTAINER | cefuroxime sodium | INJECTABLE;INJECTION | 050643-002 | Apr 28, 1989 | DISCN | Yes | No | Start Trial | Start Trial | |||||
| Teligent Pharma Inc | FLUOCINONIDE | fluocinonide | GEL;TOPICAL | 209030-001 | Jun 19, 2018 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Teligent | ZANTAC IN PLASTIC CONTAINER | ranitidine hydrochloride | INJECTABLE;INJECTION | 019593-001 | Dec 17, 1986 | DISCN | No | No | Start Trial | Start Trial | |||||
| Teligent | FORTAZ | ceftazidime | INJECTABLE;INJECTION | 050578-004 | Jul 19, 1985 | AP | RX | Yes | Yes | Start Trial | Start Trial | ||||
| Teligent | TENSILON | edrophonium chloride | INJECTABLE;INJECTION | 007959-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Teligent
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Teligent | ZANTAC IN PLASTIC CONTAINER | ranitidine hydrochloride | INJECTABLE;INJECTION | 019593-001 | Dec 17, 1986 | 4,585,790*PED | Start Trial |
| Teligent | ZANTAC | ranitidine hydrochloride | INJECTABLE;INJECTION | 019090-001 | Oct 19, 1984 | 4,128,658 | Start Trial |
| Teligent | ZANTAC IN PLASTIC CONTAINER | ranitidine hydrochloride | INJECTABLE;INJECTION | 019593-002 | Sep 27, 1991 | 4,585,790*PED | Start Trial |
| Teligent | ZANTAC IN PLASTIC CONTAINER | ranitidine hydrochloride | INJECTABLE;INJECTION | 019593-002 | Sep 27, 1991 | 4,128,659 | Start Trial |
| Teligent | ZANTAC IN PLASTIC CONTAINER | ranitidine hydrochloride | INJECTABLE;INJECTION | 019593-001 | Dec 17, 1986 | 4,521,431*PED | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
